Compare · head to head
Kirby vs Vanda Pharmaceuticals
Kirby ranks higher overall — 360 rank 94 vs 58.
Vanda Pharmaceuticals leads on Value (49 vs 40). Kirby leads on Quality (65 vs 56), Growth (72 vs 58), Safety (61 vs 51) and Sentiment (65 vs 43).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Transport & Logistics | Health Care |
| Industry | Marine | Biotechnology |
| Size | Small | Small |
| ISIN | US4972661064 | US9216591084 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 94 | 58 |
| Value | 40 | 49 |
| Quality | 65 | 56 |
| Growth | 72 | 58 |
| Safety | 61 | 51 |
| Sentiment | 65 | 43 |
| Quality details | ||
| Profitability | 71 | 52 |
| Cash Truth | 59 | 61 |
Kirby vs Vox RoyaltyKirby vs VericelKirby vs UpexiKirby vs Ultragenyx PharmaceuticalAdd a third stock →
Full analyses: Kirby · Vanda Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100